KATELYN WEBB: Open Payments
NPI 1649857012 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 39 payments from 18 companies in 2025. Trend: 2023 $120 · 2024 $611 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $147 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Astellas Pharma US Inc | 2 | $67 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Exact Sciences Corporation | 3 | $45 |
| Lilly USA, LLC | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $26 |
Products named: Veozah, Auvelity, Ozempic, FARXIGA, Rybelsus, Wegovy, VOQUEZNA, XIFAXAN.
Industry payments across SC — which companies pay providers there.
